Infection Prevention Market is projected to rise at a CAGR of 4.2% forecast period by 2031

According to a recent study by Future Market Insights (FMI), sales of infection prevention products are expected to top US$ 37.4 Bn in 2021, at a CAGR of over 4.2% during the forecast period (2021-2031).

Rising cases of infectious diseases caused due to the pathogenic organisms such as bacteria, fungi, viruses and other parasitic organism are improving the adoption of infection preventing products.

As reported by the Centre for Disease Control and Prevention (CDC) in 2018, infectious disease is the third most leading cause of death in the U.S. followed by other infectious diseases such as tuberculosis (9,025 cases), salmonella (60,99 cases), Lyme disease (33,666 cases), meningococcal disease (327 cases) and parasitic diseases (15.5 Mn cases).

Several other factors such as rising incidence of infections acquired while in hospital (often called as Hospital Acquired Infections or HAI), large number of surgical procedures, and increasing cases of chronic diseases among geriatric population have led to higher emphasis on maintaining proper hygiene and cleanliness.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13950

Sudden outbreak of pandemic increased the number of patients in hospital during the FQ-20, elevating the risk of viral transmission amongst them. This in turn has created the demand for infection preventing and controlling options such as the use of hand sanitizers, disinfectants and other such products.

Increase in sales of these infection prevention products is expected to boost the infection prevention market growth in near future. The market registered spike in demand for infection preventive products, especially in emerging economies such as India.

As per Future Market Insights, the India infection prevention market registered highest growth across South Asia, reaching US$ 17.29 Bn in 2021.

Additionally, companies manufacturing infection prevention products have been focusing on developing eco- friendly and sustainable bio-based products with superior efficacy. Drive towards sustainability is expected to strengthen infection prevention market, creating worthwhile opportunities for growth.

Increasing ageing population worldwide has resulted in higher focus on proper hygiene and self-care solutions due to the rise in chronic diseases and onset of COVID-19. Furthermore, increase in consumer spending, improved healthcare infrastructure, rising government and industry investments in research and development activities will create demand for infection prevention product.

Based on the aforementioned factors, Future Market Insights (FMI) estimates that the market is expected to create absolute $ opportunity, exceeding more than US$ 56.39 Bn by 2031-end.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-13950

Key Takeaways from Infection Prevention Market Study

• By product, sterilization equipment is the most lucrative segment in terms of revenue and is anticipated to grow at a CAGR of more than 4.9% during 2021-2031.
• Based on end-user, hospitals and clinics segment is leading the market and expected to gain more than 42% of revenue share through 2031.
• The U.S. is expected to dominate the global infection prevention market in terms of revenue in 2021, followed by the U.K. and Germany.
• India is expected to be the most lucrative market in terms of revenue across South Asia, accounting for over 50% of market value share in 2021.
• China holds leading position in East Asia and is expected to account for nearly 48% of market share.

Who is Winning?

Some of the leading manufacturers of infection prevention products are focusing on new product development, clinical trials, speedy regulatory approvals, exclusive marketing and distribution licensing agreement strategies, thereby enhancing their market presence.

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-13950

• In 2021, a new 3M Clean & Protect Certified Badge Program was launched by 3M company. A new comprehensive system designed for effective cleaning and disinfecting solution that cleans, monitors and protects the facilities.
• In July 2020, Reckitt Benckiser Group PLC in partnership with water.org made provisions for improved access to safe, clean water in Kenya. In the same month, the company received the EPA approval for the first surface disinfectant products tested on the SARS-COV-2 virus.
• In 2021, Metrex collaborated with Solvay for chemical resistance testing of widely-used disinfectants in healthcare settings.

Infection Prevention Market by Category

By Product:

• Sterilization Equipment
• Low Temperature Equipment
• Ozone Sterilizers
• Hydrogen Peroxide Sterilizers
• Formaldehyde Sterilizers
• Ethylene Oxide Sterilizers
• Other Low-Temperature
• Heat Sterilization Equipment
• Moist Heat Sterilizers
• Dry Heat Sterilizers
• Radiation Sterilization Equipment
• Liquid Sterilization Equipment
• Disinfectors
• Other

By End User:

• Hospitals & Clinics
• Pharmaceutical Companies
• Clinical Laboratories
• Medical Device Companies
• Life Sciences Industries
• Academic and Research Institutes

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs